Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology

被引:78
作者
Colvin, GA
Lambert, JF
Abedi, M
Hsieh, CC
Carlson, JE
Stewart, FM
Quesenberry, PJ
机构
[1] Roger Williams Med Ctr, Dept Res, Providence, RI 02908 USA
[2] Univ Hosp Geneva, Serv Hematol, Geneva, Switzerland
[3] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA
[4] Seattle Canc Care Alliance, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
hematopoietic stem cells; cell differentiation; bone marrow transplantation; total marrow cellularity;
D O I
10.1038/sj.leu.2403268
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In unperturbed mice, the marrow cell numbers correlate with the stem cell numbers. High levels of long-term marrow engraftment are obtained with infusion of high levels of marrow cells in untreated mice. To address the issue of stem cell competition vs 'opening space', knowledge of total murine marrow cellularity and distribution of stem and progenitor cells are necessary. We determined these parameters in different mouse strains. Total cellularity in BALB/c mice was 530+/-20 million cells; stable from 8 weeks to 1 year of age. C57BL/6J mice had 466+/-48 million marrow cells. Using these data, theoretical models of infused marrow (40 million cells) replacing or adding to host marrow give chimerism values of 7.5 and 7.0%, respectively; the observed 8-week engraftment of 40 million male BALB/c marrow cells into female hosts (72 mice) gave a value of 6.91+/-0.4%. This indicates that syngeneic engraftment is determined by stem cell competition. Our studies demonstrate that most marrow cells, progenitors and engraftable stem cells are in the spine. There was increased concentration of progenitors in the spine. Total marrow harvest for stem cell purification and other experimental purposes was both mouse and cost efficient with over a four-fold decrease in animal use and a financial saving.
引用
收藏
页码:575 / 583
页数:9
相关论文
共 30 条
[1]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[2]  
Blomberg M, 1998, EXP HEMATOL, V26, P320
[3]   MARROW MASS AND DISTRIBUTION IN MURINE SKELETONS CLEANED BY BEETLES AS COMPARED TO CUT UP CARCASSES AND A FURTHER SIMPLIFICATION OF THE LATTER TECHNIQUE [J].
BOGGS, DR ;
PATRENE, KD .
AMERICAN JOURNAL OF HEMATOLOGY, 1986, 21 (01) :49-55
[5]   Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen [J].
Bradley, MB ;
Sattler, RM ;
Raftopoulos, H ;
Ward, M ;
Grossman, IR ;
Townes, TM ;
Ryan, TM ;
Bank, A .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (08) :453-461
[6]   SPECIAL PROLIFERATIVE SITES ARE NOT NEEDED FOR SEEDING AND PROLIFERATION OF TRANSFUSED BONE-MARROW CELLS IN NORMAL SYNGENEIC MICE [J].
BRECHER, G ;
ANSELL, JD ;
MICKLEM, HS ;
TJIO, JH ;
CRONKITE, EP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (16) :5085-5087
[7]  
CRONKITE EP, 1985, EXP HEMATOL, V13, P802
[8]   A WILCOXON-TYPE TEST FOR TREND [J].
CUZICK, J .
STATISTICS IN MEDICINE, 1985, 4 (01) :87-90
[9]  
KRIEGLER AB, 1994, EXP HEMATOL, V22, P432
[10]   H2-mismatched transplantation with repetitive cell infusions and CD40 ligand antibody infusions without myeloablation [J].
Lambert, JF ;
Colvin, GA ;
Zhong, SJ ;
Wang, H ;
D'Hondt, L ;
Abedi, M ;
Frimberger, AE ;
Stewart, FM ;
Quesenberry, PJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) :155-163